cowtown jay
2 horas hace
I'm actually shocked that some of you can't process the significance of the amended Asset Purchase Agreement, which increased the number of Milestone Events, as well as increased the payment amounts contingent upon accomplishing those Milestone Events.
Nor can I understand how many of you think we can remain in bankruptcy, if all creditor obligations are met.
Also, why are only the CAR-T patents assigned to Taran?
And why does the Taran analyst believe that Taran is positioned to respond to the next covid outbreak?
Does anyone think that the most likely way Taran can respond to the next covid outbreak is to merge with us, for the shell and non-covid IP rights?
Does anyone realize that if the results of our PREACH-M and RATinG studies are confirmed by the pending interim analysis, then lenz-treated patients could prove to be cured of cancer?
Has anyone heard that, "Nipah virus is an emerging zoonotic pathogen that causes severe febrile encephalitis resulting in death in 40% to 75% of human cases."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088631/#:~:text=Nipah%20virus%20is%20an%20emerging,to%2075%25%20of%20human%20cases.
"How many small cap biotech management teams can manage to gain control of 65 - 90% of the shares they have issued? AND, get a hugely successful Phase III trial on a novel coronavirus completed within one year, while continuing their in-process trials on CMML, along with their companion trial on aGvHD, which, together, promise to eradicate several leukemias, and prevent stem cell transplant and CAR-T toxicities?" (It was worth asking that question again).
The dollar value of my Humanigen account is updated daily. Is a dollar value entered daily ahead of our pending mergers?
And have we, after all, resolved issues not only in regards to insurance payments in the bankruptcy case, but in the District Court case, as well? Just asking. It seems that management may be intent on taking legal action against Pieroni, if I'm reading things correctly, and as I have strongly felt was warranted.
cowtown jay
16 horas hace
I still fully expect to see a short squeeze, whether that has been established by being bought out, or merged, or we come out of this bankruptcy while still in possession of our covid IP, and we change our name again, as we did when we were Kalobios.
I like what Geoff Winkler said about the people he and American Fiduciary co-Founder John Hall look for.
"Winkler’s is a trust-based business. His value is earned by reaching the most equitable decision for everyone, often without guidance from laws, so his employees must be able to work independently and be critical thinkers..."
https://willamette.edu/news/library/2021/07/geoff-winkler-story.html
Couple the selection of American Fiduciary, along with the fact information remains sealed in our District Court case, even though it appears the case has already been heard on Appeal, I interpret that as management vigorously demanding justice for Humanigen and the shareholders, however we may be defined. I would be glad, at no charge, to sanitize the database I developed for tracking Cede shares, and send that to management and to Geoff, if necessary. I just hope that it won't be necessary, and that we will prevail in capturing the benefit associated with the design of our share structure.
cowtown jay
1 día hace
I think HGEN shares are canceled, by management's choice to liquidate, rather than to restructure.
However, I don't think there are any shares issued by the company that remain to be canceled. I suspect that we are still holding the covid and device patents, and that we are holding 5X the number of shares we had, collectively 595,400,675 shares, and that 238,160,270 of those shares will go to Sanofi and/or Novavax, as we announce a joint merger with them in a new entity.
I get frustrated with these bankruptcy filings because I suspect they are a waste of time. I think we will restructure, after all, and continue with our shell and resume listing, temporarily, on the OTC, before returning to Nasdaq.
Of course, this is contingent on regulatory approval of lenz to treat CMML, which will also result in meeting a bankruptcy Milestone Event, enabling management to meet all creditor obligations, and have this bankruptcy case discharged.
SorcererGuru44
1 día hace
Let me break this down the best I can.
Derivative action - This is the case filed by Chul Yang. Case # 2:23-cv-00235 which can be found here: https://www.pacermonitor.com/case/47490874/YANG_v_DURRANT_et_al
The "Claims"- is the essentially the objection filed by the committee which can be read through (kind of) on Page 12/58 of Docket 285 Section 30 here: https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1087413&projectCode=HUM&docketNumber=285&source=DM
Basically saying "Do not lift the stay, and please don't let Humanigen liquidate anymore policies because they will be unable to pay us at all. if you do let them, all of the money will go to fighting other cases which they are likely to lose, so we will have absolutely no recovery"
Then the Stay Relief Motion - Obsidian said "Hey....we have to pay those directors of humanigen otherwise they are all in trouble, and they have a right to defend themselves from the massive amounts of litigation aimed at them...so let us give them something" in Docket 216 found here: https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1073533&projectCode=HUM&docketNumber=216&source=DM
The section you are mentioning in Docket 320 is essentially trying to clear the management team of additional lawsuits by committee parties. Why would they add that? Because they have been very vocal about the potential to file claims against the management team personally and push the concept of criminality.
They are now using the policy meant to defend the management team in case of litigation to pay some of the creditors to get them to back off a bit.
Keep in mind the above mentioned items have no bearing on the SEC case against Dale which is heading for mediation (very standard for SEC cases) or Pieroni v Humanigen which has already been settled.
In mention of the omnibus, I don't personally think it matters at this stage. But I could be wrong.
cowtown jay
1 día hace
Of course, you are correct, SG44. Thank you for the clarification.
As I noted earlier:
"AMENDED MEDIATION REFERRAL ORDER: The Clerk of Court shall terminate retired-Judge FAITH HOCHBERG as mediator in this matter. The parties are referred to private mediation before retired-Judge JOSE L. LINARES. The parties shall complete mediation on or before 9/30/2024."
https://www.pacermonitor.com/public/case/52335094/SECURITIES_AND_EXCHANGE_COMMISSION_v_CHAPPELL_et_al
I got confused by this:
"J. The Parties wish to conclusively resolve all of their disputes and potential disputes
in connection with the Derivative Action, the Claims, the Stay Relief Motion, and otherwise,
without admission as to any claims or defenses, on the terms set forth below."
pg 21/32
https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1095423&projectCode=HUM&docketNumber=320&source=DM
So as far as the bankruptcy case, are we waiting for the omnibus hearing on 8/21/24, or is that moot at this point?
cowtown jay
2 días hace
A couple of things. YOU are always the one trying to create the narrative saying Taran stole the IP. I disagree.
In the first place, I think they may only have the CAR-T IP.
Secondly, our first merger moves will be with Humanigen Australia, and with Taran. Either way, our new share structure will continue to be reflective of the value of ALL of our IP.
So, yes, "...something must be going on..." Besides, why steal what you already own?
cowtown jay
2 días hace
"If I am right that the Appeals Court case was concluded, and that we are down to a private mediation at the District Court level, I hope that we can settle well before the deadline, and then enter into our restructuring agreements with our partners. I was pleased to see Geoff appointed as the receiver of the Black Horse assets after all the time he has put into this effort."
My question is, was the last filing to the bankruptcy court intended to notify the judge that mediation has resulted in the outstanding issues at the District Court level being resolved? That's how I interpret it, anyway (but I really had to force myself to try to understand the reason for the filing).
"J. The Parties wish to conclusively resolve all of their disputes and potential disputes
in connection with the Derivative Action, the Claims, the Stay Relief Motion, and otherwise,
without admission as to any claims or defenses, on the terms set forth below."
pg 9/20
https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1099674&projectCode=HUM&docketNumber=330&source=DM
I hope that I'm not misinterpreting the significance of this filing. I just don't know what else it could be, other than notice to the judge that mediation has been concluded at the District Court level.
It's hard for me to be objective, because I think a successful mediation outcome will allow us to enter into our partnership agreements with Sanofi and Novavax. If Geoff and management have determined our path, including whether to utilize Humanigen Australia, which I think is likely, I hope that results in shareholders having 5X the number of HGEN shares that we had, as lenz will be commercialized worldwide for CMML, aGvHD, as a covid therapeutic, and as a covid vaccine and CAR-T enhancement.
cowtown jay
5 días hace
"Sanofi reports two operating segments: Biopharma and Opella (formerly Consumer Healthcare – CHC).
The Biopharma operating segment comprises commercial operations and research, development and production activities relating to the Speciality Care, General Medicines and Vaccines franchises, for all geographical territories. The segment’s results include the costs of global support functions that are not within the managerial responsibility of the Opella GBU.
The Opella operating segment comprises commercial operations relating to consumer healthcare products, and research, development and production activities and global support functions (as listed above) dedicated to the segment, for all geographical territories. The Opella GBU segment’s results reflect all incurred costs of global support functions attributable to its business."
see pg 45,
D.1.1. OPERATING SEGMENTS
https://www.sec.gov/Archives/edgar/data/1121404/000112140424000016/exhibit992-2024halfyearman.htm
The Biopharma segment may be more geared to incorporating entities like Humanigen/Taran.
US-JUSTICE
5 días hace
These EXPENSE reports is mainly for the debtor as a company in 'bankruptcy' has to get court approval to spend any money.
Here is the reality, before the bankruptcy, the company had 2-3 million in cash and accounts receivables.
as of now, it has less than 300,000 in cash. so in company that is bankrupt and owes small vendors $2000 or $1000 and not paying bills, somehow it has spent $2 million in 'legals fees' to go bankrupt and not pay creditors a dime. is that justice? The company has no cash left and has no money to pay of it's lawyers. it cannot even pay any of it's employees, Why waste money in declaring bankruptcy. For most bankrupt companies, the owners just bail leave the country and don't bother with bankruptcy court. There is nothing the creditors can do if the owners of a company just takes all the money and sells everything and just close the doors and wire all the money out. But in this case, humanigen had and own assets it needed to transfer out. For the Dale, and the employees, they are just employees and not liable for anything same with employees. As for creditors who claim they are owe money. who cares, your problem of the 40 million 'claim' 95% of the money if fake claims and they didn't lose anything and humanigen owes these FAKE creditors claim nothing and should pay nothing and will not pay anything as the creditors are the 'criminals' in this case.
cowtown jay
6 días hace
I feel ya, dlog. I won't be doing any travel, either, as long as Social Security remains my sole source of income, and I can't supplement that with trading profits, as I was doing, until we had to change the track we were on.
But, to me, nothing I see indicates that our destination has changed. Still, I believe that we have never been stronger than we are now. And I can't over-emphasize what I see as the developing need for lenz. Consider evidence of that:
"The south Indian state of Kerala is battling an outbreak of Nipah: a virus that comes from bats, but which has triggered multiple human outbreaks in recent decades. The World Health Organization (WHO) lists Nipah as one of its priority pathogens: those with high epidemic potential, and for which zero or insufficient countermeasures exist. The virus is also considered a bioterrorism threat...
Before the current outbreak in India, a total 634 cases and 376 deaths had been recorded worldwide...
Also, whereas mortality during the first Bangladesh outbreak in 2001 was 69%, during the 2013 outbreak it was 83%, while an outbreak in Kerala, India in 2018 killed 17 out of the 18 people infected – a fatality rate of 94.4%...
The Bangladesh strain is associated with additional symptoms, including muscle weakness, cough and breathing difficulties and can be transmitted directly between humans, through contact with body fluids and possibly respiratory droplets produced when people cough or sneeze. The 2018 outbreak in Kerala was associated with a further symptom: heart muscle dysfunction...
Studies on the spread of Nipah virus in Bangladesh have suggested that human-to-human transmission occurs through direct contact with patients and their body secretions, such as urine, blood, and nasal or respiratory droplets. Such infections have usually occurred in hospitals among healthcare staff, caregivers or visitors, although transmission within households is also believed to have occurred...
https://www.gavi.org/vaccineswork/seven-things-you-need-know-about-nipah-virus?gad_source=1&gclid=CjwKCAjw74e1BhBnEiwAbqOAjBXEbsbh042OGVV5EmDfa0EbdCNDNqfI5euPrN3YqMrOAbQl9YbjjxoCwcAQAvD_BwE
But, have no fear. Five months after the Nipah outbreaks, selected legislators convened in a Sensitive Compartmented Information Facility (SCIF) to discuss national security issues, which hopefully included this potentially actively-unfolding pandemic, as well as other developing threats.
"Mike Johnson Urges Calm After Republican Discloses Mysterious 'National Security Threat'
Arthur Delaney
Updated February 14, 2024"
https://www.yahoo.com/news/mike-johnson-urges-calm-republicans-192533613.html
Even though members of the Hope Accord have called for a ban on mRNA vaccines, "Vaccines are being developed against (Nipah). While there are currently no approved human vaccines or treatments for Nipah, several are currently in clinical trials, including an mRNA-based vaccine, one based on a protein from the closely related Hendra virus and another that uses a harmless vesicular stomatitis virus to deliver a Nipah virus protein." We can only hope that the protein-based vaccine, such as made by Sanofi for Novavax, and enhanced with the lenz cocktail, will be selected as the Standard of Care to prevent this potential pandemic, as well as using lenz to treat infected patients, whether hospitalized or on an outpatient basis while their CRP levels are low.
cowtown jay
6 días hace
I don't think Taran acquired all of the Humanigen patents. This bankruptcy case is going to be closed out, with all creditors paid, and our merged entity could continue to use what will be the well-capitalized shell, which we'll quickly relist on the OTC with our new ticker, until Nasdaq requirements are met again. Given our share structure, regaining Nasdaq compliance won't take long. The delinquent filings have probably been completed for some time, if that will be necessary.
cowtown jay
6 días hace
It's gonna be kinda hard to make the case that Taran stole the IP from Humanigen and the shareholders, when they do a stock-for-stock (or a 5:1) merger with us. And if it does prove to be a 5:1 merger, that will only be because the entity we form with Taran, will do a further merger with Sanofi and/or Novavax, which will result in the creation of another new entity, jointly owned by HOT, Sanofi, and/or Novavax.
That's exactly the kind of justification the bankruptcy court judge would have amended the Asset Purchase Agreement to accommodate.
cowtown jay
6 días hace
Didn't we, at one time, talk about Florence and Pisa, and the Alps? I remember trying to buy Italian Ice in a local shop, and was very grateful for the translational help I got from a young American lady, living in an Italian villa that her father had bought. I didn't go further south than Pisa, so I never got to Malta, just south of Italy. But Switzerland is beautiful, just north of Italy. If I'm lucky with this investment, maybe I'll go back to the the Oberammergau part of Garmisch-Partenkirchen, and to Austria, and import crystal, wood and candle carvings, and Steifel and Goebel porcelain figurines. Maybe my daughter will appreciate owning a gift shop and not having a boss.
It's a beautiful part of the world, and relocating ex-pats and investment migrants is a cottage industry.
https://www.henleyglobal.com/services/private-clients
If I was Dale, I'd spend summer in Switzerland, and winters in Malta.
But, we basically have more and more people, here in the States, moving into new States where their values are more broadly integrated into everyday life. That most certainly applies to me, and my choice to live in Texas, and rural Texas, at that, and in what I actually consider the Republic of Texas, with my own Alamo.
Dale is fortunate enough to have the lifestyle he wants. There's no more reason to disparage him for his decision, than there is to disparage me for mine. I think we both made moves in accordance with our abilities and desires. I'm glad as hell, when my enlistment was up, I left my duty assignment in Germany, and did not go back to Youngstown, Ohio. I don't think I'd like posting as "rust bucket jay."
cowtown jay
1 semana hace
With SpongeTech, I focused on the SEC and FINRA.
Here, as soon as I saw how the share structure was designed, I knew it would be pointless for me to worry about those agencies. I believed that management was defending us appropriately and effectively against them. Besides, the FDA, the NIH, and NIAID gave us plenty to question. And the spotlight on them has just continued to shine brighter, with us gaining pharmaceutical partnering interest, as well as overall media and legislative interest increasing in regards to the safety and efficacy of the institutionalized covid prevention and treatment protocols. I am confident we will prevail in getting lenz approved and commercialized on a worldwide scale. I only hope to be able to re-enter my $200 sell orders at the right time when our trading resumes.
I think the time has arrived to finally deal with the SEC. The fact that we are doing so in mediation, versus a continued Litigation Release or Admin Proceeding, I think signifies less SEC interest in continuing to try to prosecute this case, which has likely proven not be be what they thought it was.